Sixfold Bioscience
London
About Sixfold Bioscience
Sixfold Bioscience engineers programmable oligonucleotide delivery systems are able to deliver RNA exclusively to diseased cells. It is based in London.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.6M
- Funding stage: Seed
- Last round: Seed (Dec 2021)
- Website: sixfold.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Nanotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/sixfold-bioscience-96508 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.